Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A common genetic network underlies substance use disorders and disruptive or externalizing disorders.

Arcos-Burgos M, Vélez JI, Solomon BD, Muenke M.

Hum Genet. 2012 Jun;131(6):917-29. doi: 10.1007/s00439-012-1164-4. Epub 2012 Apr 11. Review.

2.

Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci.

Jain M, Palacio LG, Castellanos FX, Palacio JD, Pineda D, Restrepo MI, Muñoz JF, Lopera F, Wallis D, Berg K, Bailey-Wilson JE, Arcos-Burgos M, Muenke M.

Biol Psychiatry. 2007 Jun 15;61(12):1329-39. Epub 2006 Sep 1.

PMID:
16950213
3.

Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.

Sobanski E, Banaschewski T, Asherson P, Buitelaar J, Chen W, Franke B, Holtmann M, Krumm B, Sergeant J, Sonuga-Barke E, Stringaris A, Taylor E, Anney R, Ebstein RP, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Steinhausen HC, Faraone SV.

J Child Psychol Psychiatry. 2010 Aug;51(8):915-23. doi: 10.1111/j.1469-7610.2010.02217.x. Epub 2010 Feb 1.

PMID:
20132417
4.

Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).

Sánchez-Mora C, Ramos-Quiroga JA, Garcia-Martínez I, Fernàndez-Castillo N, Bosch R, Richarte V, Palomar G, Nogueira M, Corrales M, Daigre C, Martínez-Luna N, Grau-Lopez L, Toma C, Cormand B, Roncero C, Casas M, Ribasés M.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1463-73. doi: 10.1016/j.euroneuro.2013.07.002. Epub 2013 Jul 29.

PMID:
23906647
5.

Externalizing disorders and substance use: empirically derived subtypes in a population-based sample of adults.

Rodgers S, Müller M, Rössler W, Castelao E, Preisig M, Ajdacic-Gross V.

Soc Psychiatry Psychiatr Epidemiol. 2015 Jan;50(1):7-17. doi: 10.1007/s00127-014-0898-9. Epub 2014 Jun 7.

PMID:
24907047
6.

Inhibitory control deficits in childhood and risk for substance use disorders: a review.

Ivanov I, Schulz KP, London ED, Newcorn JH.

Am J Drug Alcohol Abuse. 2008;34(3):239-58. doi: 10.1080/00952990802013334. Review.

PMID:
18428067
7.

Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes.

Carpentier PJ, Arias Vasquez A, Hoogman M, Onnink M, Kan CC, Kooij JJ, Makkinje R, Iskandar S, Kiemeney LA, de Jong CA, Franke B, Buitelaar JK.

Eur Neuropsychopharmacol. 2013 Jun;23(6):448-57. doi: 10.1016/j.euroneuro.2012.07.003. Epub 2012 Jul 26.

8.

Using dimensional models of externalizing psychopathology to aid in gene identification.

Dick DM, Aliev F, Wang JC, Grucza RA, Schuckit M, Kuperman S, Kramer J, Hinrichs A, Bertelsen S, Budde JP, Hesselbrock V, Porjesz B, Edenberg HJ, Bierut LJ, Goate A.

Arch Gen Psychiatry. 2008 Mar;65(3):310-8.

PMID:
18316677
9.

[Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].

Villemonteix T, Purper-Ouakil D, Romo L.

Encephale. 2015 Apr;41(2):108-14. doi: 10.1016/j.encep.2013.12.004. Epub 2014 Apr 1. French.

PMID:
24703785
10.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
11.

Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude.

Iacono WG, Malone SM, McGue M.

Int J Psychophysiol. 2003 May;48(2):147-78. Review.

PMID:
12763572
12.

Adult outcomes of attention deficit hyperactivity disorder and conduct disorder: are the risks independent or additive?

Gunter TD, Arndt S, Riggins-Caspers K, Wenman G, Cadoret RJ.

Ann Clin Psychiatry. 2006 Oct-Dec;18(4):233-7.

PMID:
17162622
13.

Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.

Skoglund C, Chen Q, Franck J, Lichtenstein P, Larsson H.

Biol Psychiatry. 2015 May 15;77(10):880-6. doi: 10.1016/j.biopsych.2014.10.006. Epub 2014 Oct 22.

PMID:
25457227
14.
15.

[Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder].

Zhang HB, Wang YF, Li J, Wang B, Yang L.

Zhonghua Er Ke Za Zhi. 2005 Jan;43(1):26-30. Chinese.

PMID:
15796803
16.

Review of the evidence base for treatment of childhood psychopathology: externalizing disorders.

Farmer EM, Compton SN, Bums BJ, Robertson E.

J Consult Clin Psychol. 2002 Dec;70(6):1267-302. Review.

PMID:
12472301
17.
18.

Electroencephalography and externalizing behavior: a meta-analysis.

Rudo-Hutt AS.

Biol Psychol. 2015 Feb;105:1-19. doi: 10.1016/j.biopsycho.2014.12.005. Epub 2014 Dec 18. Review.

PMID:
25528418
19.

Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment.

Frías Á, Palma C, Farriols N.

J Affect Disord. 2015 Mar 15;174:378-89. doi: 10.1016/j.jad.2014.12.008. Epub 2014 Dec 12. Review.

PMID:
25545605

Supplemental Content

Support Center